The billion-dollar question every pharmacy executive will face in 2025
Becker’s Hospital Review, April 28, 2025
“I think a billion-dollar question is: how can we sustainably balance rising drug costs, access to high-cost therapies, and evolving reimbursement models, while maintaining clinical excellence and financial viability?” UTMB’s Michael Eagon tells Becker’s. Eagon was one of 14 executives featured in the article.